PRF Technologies (PRFX) Common Equity (2019 - 2025)
PRF Technologies (PRFX) recorded quarterly Common Equity of $9.3 million in Q4 2025, up 409.32% on a QoQ basis from $1.8 million in Q4 2024, and up 409.32% year-over-year from $1.8 million in Q4 2024.
PRF Technologies (PRFX) Common Equity (2019 - 2025) Analysis & Trends
PRF Technologies has disclosed Common Equity across 7 years of filings, most recently posting $9.3 million for Q4 2025.
- Quarterly Common Equity rose 409.32% year-over-year to $9.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.3 million (up 409.32% YoY) and the FY2025 annual result came in at $9.3 million, up 409.32% from the prior year.
- Common Equity improved to $9.3 million in Q4 2025, from $1.8 million in the prior quarter.
- Over five years, Common Equity peaked at $20.4 million in Q1 2021 and troughed at $1.8 million in Q4 2024.
- A 5-year average of $11.3 million and a median of $10.2 million in 2022 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2024 — Common Equity plunged 74.8% — and 2025, when it jumped 409.32%.
- Tracing PRFX's Common Equity over 5 years: stood at $18.1 million in 2021, then plunged by 39.05% to $11.0 million in 2022, then tumbled by 34.32% to $7.2 million in 2023, then tumbled by 74.8% to $1.8 million in 2024, then soared by 409.32% to $9.3 million in 2025.
- Business Quant data shows PRFX's Common Equity at $9.3 million in Q4 2025, $1.8 million in Q4 2024, and $7.2 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 446.17 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.21 Bn |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - | 9.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.29 Mn |
| Dec 31, 2024 | 1.82 Mn |
| Dec 31, 2023 | 7.24 Mn |
| Dec 31, 2022 | 11.02 Mn |
| Dec 31, 2021 | 18.08 Mn |
| Mar 31, 2021 | 20.40 Mn |
| Dec 31, 2020 | 16.62 Mn |
| Dec 31, 2019 | -12.24 Mn |